Two projects by staff from the Hospital del Mar and the Hospital del Mar Medical Research Institute (IMIM) have been awarded funding by the Spanish Society of Medical Oncology as part of its 2021 grants. The awards were presented on 13 October in Madrid and represent a new record for the organisation, with 44 scholarships and grants awarded with an endowment of nearly 1.4 million euros. All the money is earmarked for research and the training of medical professionals to improve the survival and quality of life of cancer patients.
18/10/2021 - General information
These new grants are linked to the Spanish Government's Recovery, Transformation and Resilience Plan and are co-financed by the European Union's Next-Generation funds. Four projects involving the IMIM will benefit. Four research projects led by or involving researchers from the Hospital del Mar Medical Research Institute (IMIM) will receive funding from the State Research Agency (Agència Estatal d'Investigació), as part of the aid promoted in Spanish and European plans linked to recovery from the COVID-19 pandemic. In total of, each project will receive just over 790,000 euros from these funds.
05/11/2021 - General information
A study led by the Colon and Rectal Surgery Unit, part of the Surgery Service at Hospital del Mar, has received two research grants, one from the Catalan Society of Surgery during the inaugural ceremony of the academic year on 15 October; and another from the Spanish Association of Coloproctology, during the organisation's conference, held from 20 to 22 October. The funding goes towards a multicentre project entitled 'Determining proangiogenic proteins in serum as a prognostic factor for recurrence after curative colon cancer surgery', led by Dr. Marta Pascual, head of the Colon and Rectal Surgery Unit, and Dr. Clara Téllez, a resident in the same department, in collaboration with Dr. Xavier Mayol, a researcher in the Cancer Research Programme at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar).
21/10/2021 - General information
The Spanish Society of Epidemiology (SEE) in its XVII edition has awarded the "Prize for research by young researchers. Edition 2021: Miguel Carrasco" to Natàlia Soldevila-Domènech, predoctoral researcher of the Integrative Pharmacology and Systems Neuroscience research group at IMIM, for the project "Analysis of trajectories of cognition evaluated in a continuous manner with cognitive training tasks in older adults at risk of Alzheimer 's disease". The work aims to evaluate the feasibility, validity and reliability of a measure of cognition obtained from the performance on self?administered computerized cognitive training tasks, and to identify and characterize subgroups of elderly individuals following a similar cognitive trajectory during the course of a preventive intervention for cognitive decline (PENSA Study).
20/10/2021 - General information
Patients with chronic kidney disease treated with bisphosphonates have a 15% higher risk of disease progression, although it is not linked to a higher rate of acute kidney injury, gastrointestinal events or hypocalcaemia. The study warns of the importance of assessing the stage of severity of CKD before prescribing bisphosphonates, as "They can worsen renal function and, in these cases, alternative treatments should be sought."
18/10/2021 - General information
These new grants are linked to the Spanish Government's Recovery, Transformation and Resilience Plan and are co-financed by the European Union's Next Generation funds. Four projects involving the IMIM will benefit. Four research projects led by or involving researchers from the Hospital del Mar Medical Research Institute (IMIM) will receive funding from the State Research Agency (Agència Estatal d'Investigació), as part of the aid promoted in Spanish and European plans linked to recovery from the COVID-19 pandemic. In total of, each project will receive just over 790,000 euros from these funds.
15/10/2021 - General information
From October 18 to 23, the PRBB and its centers invite you to participate in the open day of the Barcelona Biomedical Research Park and get inside the research they do. This time the format will be hybrid and will combine premieres, streaming activities and the first face-to-face event after the pandemic, a round table on the importance of the gender perspective in biomedical research. Throughout the week we will present a series of short videos from the different centers on Neuropharmacology, Cell Biology, Biobanks, Evolution and Cancer that will be released on the PRBB Youtube channel. On the same channel we will make live visits to laboratories investigating the effects of air pollution, synthetic biology and CRISPR, blood stem cells, proteomics and 3D microscopy. And fromInstagram we will broadcast live interviews between three researchers / as and three Instagramers, specialized in science.
05/10/2021 - General information
With this new group, the Carlos III Health Institute's Networked Biomedical Research Centre aims to unite Spain's scientific excellence in this field to enable better funding in emerging diseases, such as COVID-19, and other research areas, including antimicrobial resistance and HIV-AIDS, in which Hospital del Mar and IMIM researchers have a great deal of experience. The Infectious Pathology and Antimicrobial Research Group (IPAR) at the Hospital de Mar Medical Research Institute (IMIM) will form part of the new CIBER on Infectious Diseases. The purpose of this new group is to promote research in this field in Spain by offering new structural funding tools.
Més informació "Hospital del Mar and IMIM to participate in the new CIBER on infectious diseases"
13/09/2021 - General information
The editorial team of this prestigious publication, the third most important in respiratory medicine according to impact factor, has invited the consultant physician from the Pneumology Department and researcher at the Hospital del Mar Medical Research Institute, to collaborate with them. Dr. Esther Barreiro has joined the editorial team at the European Respiratory Society, as Associate Editor of the European Respiratory Journal (ERJ). Her role involves assisting the journal's senior editors to select potentially interesting manuscripts for publication, as well as inviting reviewers and providing advice on publication decisions. She will also write editorials for publication.
09/09/2021 - General information
A study lead by researchers from the Hospital del Mar Medical Research Institute (IMIM) and the Centre for Cellular and Molecular Biology of the Council Of Scientific And Industrial Research (CSIR) published in the Science Advances journal, shows for the first time how cholesterol can interfere with the function of a important receptor present in brain cells - the serotonin receptor. This finding is of great importance, as it allows to devise new ways to modulate those receptors, which in the future could lead to the development of new drugs to treat diseases of the central nervous system. Cholesterol is an essential component of the neuron membrane. Multiple proteins reside within those membranes, including GPCRs (G-protein coupled receptors). GPCRs are a large receptor family, encompassing serotonin receptors, which act as cellular receptors, detecting outside signals and transmitting towards the cell. Because of this, GPCRs are crucial for correct communications between cells.
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
